PARASAL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Parasal, and when can generic versions of Parasal launch?
Parasal is a drug marketed by Panray and is included in one NDA.
The generic ingredient in PARASAL is aminosalicylate sodium. There are three drug master file entries for this compound. Additional details are available on the aminosalicylate sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PARASAL?
- What are the global sales for PARASAL?
- What is Average Wholesale Price for PARASAL?
Summary for PARASAL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 151 |
Patent Applications: | 3,463 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PARASAL at DailyMed |
![PARASAL drug patent expirations Drug patent expirations by year for PARASAL](/p/graph/s/t/PARASAL-patent-expirations.png)
US Patents and Regulatory Information for PARASAL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Panray | PARASAL | aminosalicylic acid | TABLET;ORAL | 006811-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Panray | PARASAL SODIUM | aminosalicylate sodium | TABLET;ORAL | 006811-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Panray | PARASAL | aminosalicylic acid | TABLET;ORAL | 006811-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Panray | PARASAL SODIUM | aminosalicylate sodium | TABLET;ORAL | 006811-011 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |